This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Science Daily - Heart Disease
MARCH 5, 2025
Research shows that a common type of diabetes medication could help cancer patients make a better long-term recovery. Many cancer patients go on to develop heart failure -- because of the cancer itself and also due to chemotherapy.
99 
Med Page Today
JULY 5, 2024
(MedPage Today) -- GLP-1 receptor agonists lowered the risk of several obesity-associated cancers, a retrospective analysis of electronic health records suggested. Compared with insulin, GLP-1s were associated with a lower risk for developing.
116 
Med Page Today
APRIL 10, 2024
(MedPage Today) -- A Scandinavian cohort study suggested a popular class of diabetes drug did not put patients at an elevated risk for thyroid cancer, a longtime lingering concern with this drug class. Compared with DPP-4 inhibitors, patients.
124 
Med Page Today
DECEMBER 7, 2023
(MedPage Today) -- Taking glucagon-like peptide 1 (GLP-1) receptor agonists for type 2 diabetes was associated with greater reductions in colorectal cancer (CRC) risk compared with several other diabetes medication classes, a nationwide cohort.
97 
Medical Xpress - Cardiology
MARCH 6, 2025
A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research from the University of East Anglia.
78 
Med Page Today
JANUARY 23, 2025
(MedPage Today) -- More thyroid cancers were detected soon after starting a GLP-1 receptor agonist than other diabetes drugs, a secondary analysis of a target trial emulation of a comparative effectiveness study found. Of over 350,000 adults with.
111 
HCPLive
JANUARY 24, 2025
GLP-1 RA initiation boosted new thyroid cancer diagnoses, compared with other anti-diabetic drugs, but enhanced early detection may have played a role.
104 
Med Page Today
FEBRUARY 3, 2024
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.
115 
Medical Xpress - Cardiology
SEPTEMBER 12, 2024
A UCLA-led research team has found that a gene mutation that affects insulin signaling in the heart may raise the risk of deadly abnormal heart rhythms in a subset of patients with cancer and could have implications for those with diabetes and obesity.
79 
Med Page Today
NOVEMBER 8, 2024
Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of. (MedPage Today) -- Note that some links may require registration or subscription.
111 
HCPLive
FEBRUARY 8, 2024
A new study found balance and falling were linked to an increased risk of all-cause mortality, as well as cause-specific mortality from cardiovascular disease and diabetes.
Dr. Paddy Barrett
FEBRUARY 21, 2025
The reason excess weight is such big issues are the health consequences it confers with increased rates of diabetes, heart disease, osteoarthritis, obstructive sleep apnea, non-alcoholic fatty liver disease and others, just to name a few. Avoiding diabetes and its precursor states inclduing insulin resistance is key. NEJM Nov 13 2024
77 
Cardiometabolic Health Congress
JANUARY 30, 2024
Dr. Hallberg passed in March of 2022 after a 5-year battle with stage IV lung cancer. As an expert on metabolic control and type 2 diabetes (T2D), Dr. Hallberg once gave a TedTalk titled Reversing Type 2 diabetes starts with ignoring the guidelines , which quickly accumulated 8.6
105 
Frontiers in Cardiovascular Medicine
DECEMBER 13, 2023
It has been shown that patients with cancer have a longer expected life duration, benefiting from advanced medical therapy. A growing number of studies have elucidated the association between cancer and CVD. Moreover, different types of cancer have distinct risks, which may increase the complexity of antithrombotic therapy.
Frontiers in Cardiovascular Medicine
FEBRUARY 12, 2025
Sensitivity analyses reconfirmed the robustness of the associations of CVD and hypertension with COPD severity among patients who excluded bronchiectasis, tuberculosis, lung cancer, pulmonary hypertension, pulmonary heart disease, and diabetes (P<0.05).ConclusionThe
52 
Journal of the American Heart Association
FEBRUARY 26, 2025
BackgroundThere existed bidirectional associations of cardiovascular disease (CVD) and type 2 diabetes (T2D) with cancer, partly attributed to their shared risk factors. This highlighted the significance of maintaining high CVH throughout the life span for the primary prevention of CVD, T2D, and cancer.
45 
Frontiers in Cardiovascular Medicine
FEBRUARY 27, 2024
Cancer and cardiovascular disease represent the two leading causes of morbidity and mortality worldwide. However, this comes at a cost with more women developing diabetes, hypertension and coronary artery disease as they age. Women continue to enjoy a greater life expectancy than men.
DAIC
FEBRUARY 14, 2025
Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes. For patients with no other options, amputation may become imminent.
Journal of Clinical Investigation - Cardiology
JULY 15, 2024
These circadian mechanisms represent potential pathophysiological pathways linking circadian disruption to adverse metabolic health outcomes, including obesity, metabolic syndrome, and type 2 diabetes.
111 
NEJM Journal Watch - Cardiology
OCTOBER 15, 2024
An observational study suggests a protective association in patients with diabetes.
69 
Dr. Paddy Barrett
JANUARY 16, 2024
Cardiovascular disease, cancer and dementia account for 60% of all deaths in the US. Let’s start with Cancer. Compared to those who had ‘Low’ lifestyle scores, those with ‘Ideal’ scores were 27% less likely to be diagnosed with cancer in the next ten years. The leading causes of death are clear.
94 
Dr. Paddy Barrett
APRIL 26, 2024
On the far end of that line is type two diabetes. Insulin resistance and diabetes may not ‘ cause ’ coronary artery disease, but they are huge accelerants. Compared to someone without type 2 diabetes, the person with type 2 diabetes has a risk that is tenfold higher 1. Let me be 100% clear, however.
104 
Journal of the American Heart Association
DECEMBER 12, 2023
BackgroundPostpancreatectomy diabetes can be caused by resection of functioning pancreatic tissue and is associated with postoperative pancreatic islet cell mass loss and subsequent endocrine dysfunction. Diabetes is a well‐known risk factor for ischemic heart disease. Journal of the American Heart Association, Ahead of Print.
Dr. Paddy Barrett
AUGUST 23, 2024
While I have covered many of these fitness measures individually in previous posts, I wanted to summarise these metrics and how they relate to living longer and preventing major diseases such as cardiovascular disease, cancer and dementia. A higher daily step count is also linked to significantly lower cancer, stroke and heart disease rates.
116 
Heart BMJ
APRIL 15, 2024
Methods Participants with human epidermal growth factor receptor 2-positive breast cancer treated with trastuzumab±anthracycline ≥5 years previously were identified from a clinical database. mmol/L and 5% had a new diagnosis of diabetes. All participants had normal LVEF prior to, and on completion of, treatment.
52 
Journal of the American Heart Association
MARCH 19, 2025
BackgroundCardiotoxicity in patients with cancer treated with anthracyclines is associated with increased morbidity and mortality. Hypertension, diabetes, hyperlipidemia, obesity, and low socioeconomic status were more common in NH Black and Hispanic individuals. Journal of the American Heart Association, Ahead of Print. NH Black, 38.5%
40 
HCPLive
MARCH 19, 2024
The biosimilar recombinant human growth hormone, somatropin, was found to be well-tolerated; only 1.6% of pediatric patients had adverse events suspected to be caused by the injection.
59 
Dr. Paddy Barrett
OCTOBER 11, 2024
Obesity is the second leading cause of preventable cancers after smoking 9. Anything that reduces obesity has the potential to reduce future risks of any associated cancers. Colorectal Cancer - 46% reduction. Kidney Cancer - 24% reduction. Liver Cancer - 53% reduction. Pancreatic Cancer - 59% reduction.
79 
CardiacWire
SEPTEMBER 27, 2024
Better treatments have led to improved cancer survival rates, but new research reveals increased cardiovascular complications in survivors. However, another new study offers hope, suggesting that heart medications like SGLT2 inhibitors may help prevent cancer-related heart disease. smoking) and cancer-induced risk factors (e.g.
59 
Dr. Paddy Barrett
SEPTEMBER 13, 2024
Everyone sits somewhere on the scale of insulin sensitivity from very insulin sensitive to very insulin resistant at the point of type 2 diabetes. Understanding where you sit on this continuum is a key part of defining your future risk of heart disease but also dementia, and many cancers. Measuring Insulin Resistance. Some complex.
105 
Dr. Paddy Barrett
AUGUST 9, 2024
More than heart disease or cancer, the risk of dementia often creates much greater anxiety in the patients I see. Diabetes & Insulin Resistance Type 2 diabetes is when insulin resistance reaches the point where blood sugar levels can no longer be kept in range. J Diabetes Investig. But can dementia be prevented?
114 
Stroke: Vascular and Interventional Neurology
NOVEMBER 9, 2023
Type 2 Diabetes Mellitus (T2DM) is a rapidly growing global health problem with increasing prevalence. Of those patients, 35.43% (n=273,993) were diabetic and 64.57% (n=151,112) were non‐diabetic. Diabetics were more likely to be younger (70.43 Among diabetics, readmitted patients were more likely to be older (71.87
40 
Dr. Paddy Barrett
DECEMBER 12, 2023
Many pharmacies ran out of stock, and access was often restricted to keep available supplies for diabetics where the drug class had originally been developed. There is even emerging evidence that the use of such therapies may even reduce the risk of colorectal cancer by up to 50% 6. Will These Therapies Always Be Injectables?
105 
ECG Cases
JULY 30, 2024
Compassion in not simply innate; like any behaviour, it can be learned through deliberate practice.
52 
Dr. Paddy Barrett
FEBRUARY 13, 2024
A 10 to 15kg weight loss in those who are overweight can reverse diabetes in 57% of patients with diabetes 1. Even in diabetics of normal weight (BMI<27), weight loss can reverse diabetes 2. 2 1184-P: Return to Normal Glucose Control by Weight Loss in Nonobese People with Type 2 Diabetes: The ReTUNE Study.
103 
DAIC
FEBRUARY 14, 2025
Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes. For patients with no other options, amputation may become imminent.
52 
CardiacWire
AUGUST 18, 2024
Half of the 10 meds in the ‘Class of 2026’ treat cardiovascular conditions, and these heart drugs saw some of the largest reductions: Novartis’ HF drug Entresto (-53% to $295) BMS’ anticoagulant Eliquis (-56% to $231) Janssen’s anticoagulant Xarelto (-62% to $197) BI/Lilly’s HF and diabetes drug Jardiance (-66% to $197) AstraZeneca’s HF, diabetes, (..)
59 
Frontiers in Cardiovascular Medicine
NOVEMBER 19, 2024
MethodsThis prospective cohort study included 43,735 participants, who participated in three consecutive health examinations in 2006, 2008, 2010 and had no history of CMD or cancer. Moreover, cum NHHR was positively correlated with the absolute risk of CMD, cardiovascular diseases (CVD), and type 2 diabetes (T2DM).ConclusionsHigher
59 
DAIC
FEBRUARY 29, 2024
12:15 p.m. 12:15 p.m.
103 
DAIC
MAY 8, 2024
If inflammation is successfully controlled, diseases – such as arthritis, pulmonary hypertension, Crohn's disease, inflammatory bowel diseases, diabetes, cancer and autoimmune diseases – can be treated more effectively.
115 
Hypertension Journal
DECEMBER 7, 2023
ETs were shown to play important roles among others, in systemic hypertension, particularly when resistant or difficult to control, and in pulmonary hypertension, atherosclerosis, cardiac hypertrophy, subarachnoid hemorrhage, chronic kidney disease, diabetic cardiovascular disease, scleroderma, some cancers, etc.
Dr. Paddy Barrett
APRIL 12, 2024
Similar patterns have been observed for cardiovascular disease and also cancer. Less diabetes. Over a 10-year time frame, compared to 4000 steps, taking 7000 steps every day resulted in a 51% reduction in all-cause mortality. Taking 12,000-a-day steps led to a 65% reduction 5. The relationship is clear. More movement. Longer life.
124 
Physiologically Speaking
DECEMBER 27, 2023
The throng of epidemiological evidence hasn’t helped either — one week “butter is back” and the next, red meat is giving us diabetes. These gene-nutrient interactions influence things like the microbiome and gene expression, thereby influencing our risk for diseases like obesity, diabetes, and cardiovascular disease.
69 
Physiologically Speaking
SEPTEMBER 6, 2024
Diabetes, cardiovascular disease, cancer, Alzheimer’s disease, depression. Insulin resistance (characteristic of type 2 diabetes) causes a dysregulation in GLUT4 translocation and glucose uptake capacity. The sedentary participants may not have diabetes now , but they might later. .): Of occupations, etc.,
111
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content